Denial of methotrexate prescriptions post-Roe yields ‘condemnation’
The June 24 Supreme Court decision to overturn Roe vs. Wade continues to reverberate across all of health care, including rheumatology, dermatology and cancer treatment — and in this instance all three at once.Just 2 weeks after the Dobbs vs. Jackson decision, anecdotal reports began to emerge of patients being denied methotrexate prescriptions because the drug has been used to end ectopic pregnancies.Steven Newmark, JD, MPA, chief legal officer and director of policy at the Global Healthy Living Foundation, explained these reports.“So far, we have heard of two scenarios regardingRead More
